MoonLake Immunotherapeutics (MLTX) Sector Health Care
(Current)
$44.21 0.85 (1.96%)
Open Price: 44.21
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients